Global Healthcare Intelligence/Markets/Regulatory Navigator/Global
← Egypt intelligence
CURRENTLast verified 2026-10-07

Unique device identification requirements in Egypt

Country
Egypt
Official organization
Egyptian Drug Authority (EDA)
Category
standards compliance
Product / sector
Medical Devices & IVDs
Publication / issue date
2026-05
Document version
02/2026
Official source
Regulatory Guideline on Requirements for Unique Device Identification (UDI) for Medical Devices

OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK

What you need to know

  • EDA UDI guidance covers devices, accessories and IVDs supplied to Egypt, with specified exclusions for research-use, investigational and custom-made products.
  • Manufacturers, agents, importers, distributors and healthcare providers fall within its stated stakeholder scope. Review the full requirements and conditions.

This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.

Who is affected

  • Manufacturers
  • Agents
  • Importers
  • Distributors
  • Healthcare providers

PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT

Pharma Gate Intelligence

Assess applicability before planning identification, labelling and associated data work. Scope exclusions and compliance conditions must remain part of the assessment.

Business impact

Identification and data readiness may affect market-entry preparation.

RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION

What to check

  • Device / IVD classification and exclusions
  • Applicable identification and data requirements
  • Relevant compliance provisions in the current guideline

Recommended next step

Conduct a product-specific UDI applicability and compliance review.

  1. Medical Device / IVD
  2. Egypt
  3. UDI applicability
  4. Identification / data requirements
  5. Compliance review
  6. Market entry support

NEXT STEP

Need help navigating this requirement?

Pharma Gate is not a regulatory authority. Professional providers are independent organizations subject to platform review.

VERIFIED SOURCE GOVERNANCE

Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.

How we verify intelligence

Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.

Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.